Computed tomography densitometry and morphology of radiofrequency ablated Stage IA non-small cell lung cancer: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial Alexander, Erica S. , Xiong, Lillian , Baird, Grayson L. ... - - Journal of Vascular and Interventional Radiology - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033
Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography Dukes, Kimberly , Seaman, Aaron T. , Hoffman, Richard M. ... - - Ann. Otol. Rhinol. Laryngol. - 2020 Manuscript - No-Endpoint Endpoint - Primary Analysis - Prevention - Pilot
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance). Klepin, Heidi D , Ritchie, Ellen , Major-Elechi, Brittny ... - - J Geriatr Oncol - 2020 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - CALGB-361006
Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial. Parsons, J Kellogg , Zahrieh, David , Mohler, James L ... - - JAMA - 2020 Manuscript - Primary Endpoint - Primary Analysis - Prevention - CALGB-70807
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. Schenk, Erin L , Mandrekar, Sumithra J , Dy, Grace K ... - - J Thorac Oncol - 2020 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0923
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Trifiletti, Daniel M , Ballman, Karla V , Brown, Paul D ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Neuro-Onc - N107C
